Sino Cost Of Revenue from 2010 to 2025

688108 Stock   10.88  0.17  1.59%   
Sino Medical's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 170.3 M this year. From 2010 to 2025 Sino Medical Cost Of Revenue quarterly data regression line had arithmetic mean of  70,210,660 and r-squared of  0.67. View All Fundamentals
 
Cost Of Revenue  
First Reported
2019-06-30
Previous Quarter
45.6 M
Current Value
36.1 M
Quarterly Volatility
11 M
 
Covid
Check Sino Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sino Medical's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Selling General Administrative of 82.7 M or Total Revenue of 246.2 M, as well as many indicators such as . Sino financial statements analysis is a perfect complement when working with Sino Medical Valuation or Volatility modules.
  
This module can also supplement various Sino Medical Technical models . Check out the analysis of Sino Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Sino Stock

Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.